Date: 2017-09-21
Type of information: Opening of new premises
Compound: headquarters and research facility
Company: Juno Therapeutics (USA - WA)
Therapeutic area: Cancer - Oncology
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On September 21, 2017, Juno Therapeutics unveiled its new headquarters and research facility, located in the heart of South Lake Union in Seattle. The new headquarters brings together Juno’s Seattle employees – previously spread among three locations – enabling the company’s scientists, researchers, technical professionals and administrative staff to work collaboratively in a state-of-the-art facility.
Financial terms:
Latest news:
Is general: Yes
